Uranium Royalty Corp. UROY
Set alert
At close
Pre-market · Nov 3, 7:53 AM ET
- YTD
- -8.19%
- 1 year
- -22.80%
- Open
- 3.39
- Prev close
- 3.35
- Mkt cap
- 1.24B
- Vol
- 2.48M
- Avg vol
- 3.20M
- EPS
- 0.38
- P/E
- 8.55
- Div yield
- 0.00%
More statistics
- Low
- 3.21
- High
- 3.45
- Forward P/E
- 326.01
- Beta
- 1.47
- Short ratio
- 3.41
- Inst. own
- 32.47%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 10, 2026
- 50-d avg
- 4.08
- 200-d avg
- 3.76
- 1y target
- 4.39
5D chart
Signals (65)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:55 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 3:40 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 3:40 PM | 16 hours ago |
| SMA: Bearish | Nov 2, 3:35 PM | 16 hours ago |
| MACD: Buy Signal | Nov 2, 2:45 PM | 17 hours ago |
| RSI: Oversold | Nov 2, 1:25 PM | 18 hours ago |
| RSI: Oversold | Nov 2, 1:10 PM | 18 hours ago |
| RSI: Oversold | Nov 2, 12:45 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 11:30 AM | 20 hours ago |
| SMA: Bullish | Nov 2, 11:10 AM | 20 hours ago |
| MACD: Sell Signal | Nov 2, 10:30 AM | 21 hours ago |
| RSI: Overbought | Oct 30, 3:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:15 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 1:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 1:05 PM | 3 days ago |
| RSI: Oversold | Oct 30, 11:40 AM | 3 days ago |
Newest 20 of 65.
News
-
2 weeks ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Uranium Royalty, Maintains $4.5 Price Target
HC Wainwright & Co. analyst Heiko F. Ihle reiterates Uranium Royalty (NASDAQ:UROY) with a Buy and maintains $4.5 price target.
-
1 month ago benzinga.com
Uranium Royalty Q1 EPS $0.10 Beats $0.06 Estimate, Sales $50.967M Up From $24.245M YoY
Uranium Royalty (NASDAQ:UROY) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.06 by 66.67 percent. This is a 900 percent increase over earnings of $0.01…
-
3 months ago benzinga.com
Uranium Royalty Receives Shareholders' Approval For Proposed Acquisition Of 92% Stake Of Sweetwater Investors; CFO Andy Marshall Stepping Down, Effective July 29; Succeeded By Eason Chen
Uranium Royalty Corp. (NASDAQ:UROY) (TSX:URC) ("URC" or the "Company") is pleased to announce shareholder approval of its previously announced plan of arrangement, as contemplated by an arrangement
-
3 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Uranium Royalty, Maintains $4.5 Price Target
HC Wainwright & Co. analyst Heiko F. Ihle reiterates Uranium Royalty (NASDAQ:UROY) with a Buy and maintains $4.5 price target.
-
8 months ago benzinga.com
'Bill Gates-Backed TerraPower Wins US Approval For Advanced Nuclear Reactor' - Financial Post
https://financialpost.com/pmn/business-pmn/bill-gates-backed-terrapower-wins-us-approval-for-advanced-nuclear-reactor
9 months ago benzinga.com
Trump Champions Atomic Energy At Davos—Nuclear Stocks Climb
Pure-play nuclear and uranium stocks saw immediate enthusiasm as investors rallied behind Trump's bullish comments from Davos.
1 year ago benzinga.com
Why J.B. Hunt Transport Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Why J.B. Hunt Transport Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
Reported October 14, 2025: 'Army Announces Janus Program For Next-Generation Nuclear Energy' - U.S. Army
https://www.army.mil/article/288903/army_announces_janus_program_for_next_generation_nuclear_energy
1 year ago benzinga.com
Oklo And Other Nuclear Stocks — Powered By The Department Of Energy
The DOE's Defense Production Act Consortium, including Oklo and others, gathered for its first meeting on Tuesday.
-
1 year ago benzinga.com
'US Looks to Boost Strategic Uranium Reserve for Nuclear Power'- Bloomberg
https://www.bloomberg.com/news/articles/2025-09-15/us-looks-to-boost-strategic-uranium-reserve-for-nuclear-power
-
1 year ago benzinga.com
Uranium Royalty Q1 EPS $0.01 Beats $(0.01) Estimate, Sales $24.173M Up From $7.985M YoY
Uranium Royalty (NASDAQ:UROY) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.01) by 200 percent. The company reported $24.173 million in sales this…
1 year ago benzinga.com
D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday
D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday
-
1 year ago benzinga.com
Uranium Royalty To Acquire A New Royalty On Aberdeen Uranium Project In Nunavut, Canada Operated By Forum Energy Metals For C$1M
Uranium Royalty Corp. (NASDAQ:UROY) (TSX:URC) ("URC" or the "Company") is pleased to announce that it has entered into an agreement to acquire a new royalty on the Aberdeen Uranium Project in…
-
1 year ago benzinga.com
HC Wainwright & Co. Maintains Buy on Uranium Royalty, Lowers Price Target to $4.5
HC Wainwright & Co. analyst Heiko Ihle maintains Uranium Royalty (NASDAQ:UROY) with a Buy and lowers the price target from $7.7 to $4.5.
-
1 year ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Uranium Royalty, Maintains $7.7 Price Target
HC Wainwright & Co. analyst Heiko Ihle reiterates Uranium Royalty (NASDAQ:UROY) with a Buy and maintains $7.7 price target.
-
2 years ago benzinga.com
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
-
2 years ago benzinga.com
B. Riley Securities Initiates Coverage On Uranium Royalty with Buy Rating, Announces Price Target of $3.5
B. Riley Securities analyst Matthew Key initiates coverage on Uranium Royalty (NASDAQ:UROY) with a Buy rating and announces Price Target of $3.5.
-
2 years ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Uranium Royalty, Maintains $7.7 Price Target
HC Wainwright & Co. analyst Heiko Ihle reiterates Uranium Royalty (NASDAQ:UROY) with a Buy and maintains $7.7 price target.
-
2 years ago benzinga.com
Reported Earlier, "World's Largest Uranium Producer Slashes Production Target" - Financial Times
https://www.ft.com/content/240af090-8684-49dc-a85e-20b535d62dda
-
2 years ago benzinga.com
AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session
AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session
-
2 years ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Uranium Royalty, Maintains $7.7 Price Target
HC Wainwright & Co. analyst Heiko Ihle reiterates Uranium Royalty (NASDAQ:UROY) with a Buy and maintains $7.7 price target.
-
2 years ago benzinga.com
Uranium Executives Anticipated Russian Nuclear Fuel Ban Despite Senate Delay
US Senate voted to ban nuclear fuel from Russia, after months of delay, to decrease Russia's funding for war in Ukraine. Executives expect ban.
-
2 years ago benzinga.com
HC Wainwright & Co. Maintains Buy on Uranium Royalty, Raises Price Target to $7.7
HC Wainwright & Co. analyst Heiko Ihle maintains Uranium Royalty (NASDAQ:UROY) with a Buy and raises the price target from $6.4 to $7.7.
-
2 years ago benzinga.com
Why Uranium Stocks Are Climbing Today
Uranium prices are higher after a major uranium producer announced it could experience a production shortfall.
-
2 years ago benzinga.com
HC Wainwright & Co. Maintains Buy on Uranium Royalty, Raises Price Target to $6.4
HC Wainwright & Co. analyst Heiko Ihle maintains Uranium Royalty (NASDAQ:UROY) with a Buy and raises the price target from $6.2 to $6.4.
-
3 years ago benzinga.com
PagerDuty, John Wiley & Sons, Ventyx Biosciences And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Tuesday. Here are some big stocks recording losses in today’s session.
-
3 years ago benzinga.com
HC Wainwright & Co. Maintains Buy on Uranium Royalty, Raises Price Target to $6.2
HC Wainwright & Co. analyst Heiko Ihle maintains Uranium Royalty (NASDAQ:UROY) with a Buy and raises the price target from $6 to $6.2.
-
3 years ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Uranium Royalty, Maintains $6 Price Target
HC Wainwright & Co. analyst Heiko Ihle reiterates Uranium Royalty (NASDAQ:UROY) with a Buy and maintains $6 price target.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 147 stocks made new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 149 stocks hit new 52-week lows.
-
3 years ago benzinga.com
HC Wainwright & Co. Maintains Buy on Uranium Royalty, Raises Price Target to $6
HC Wainwright & Co. analyst Heiko Ihle maintains Uranium Royalty (NASDAQ:UROY) with a Buy and raises the price target from $5.9 to $6.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 337 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 479 stocks made new 52-week lows.
-
3 years ago benzinga.com
Earnings Scheduled For December 14, 2022
Companies Reporting Before The Bell • Wells Fargo (NYSE:WFC) is estimated to report earnings for its third quarter.
-
3 years ago benzinga.com
Dow Surges 400 Points; Crude Oil Down 1%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.
-
3 years ago benzinga.com
Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.
-
4 years ago benzinga.com
Lululemon To Surge Over 20%? Plus Wedbush Predicts $370 For Domino's
Piper Sandler raised Lululemon Athletica Inc. (NASDAQ: LULU) price target from $320 to $350. Lululemon shares fell 2.8% to close at $289.85 on Monday.
-
4 years ago benzinga.com
HC Wainwright & Co. Maintains Buy on Uranium Royalty, Raises Price Target to $5.9
HC Wainwright & Co. analyst Heiko Ihle maintains Uranium Royalty (NASDAQ:UROY) with a Buy and raises the price target from $5.7 to $5.9.
-
4 years ago benzinga.com
US Stocks Turn Higher, Nasdaq Jumps 100 Points
U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday.
-
4 years ago benzinga.com
Dow Drops 100 Points; US Jobless Claims Fall Further Last Week
U.S. stocks traded mostly lower this morning, with the Dow Jones dropping 100 points on Thursday.
-
4 years ago benzinga.com
HC Wainwright & Co. Maintains Buy on Uranium Royalty, Raises Price Target to $5.7
HC Wainwright & Co. analyst Heiko Ihle maintains Uranium Royalty (NASDAQ:UROY) with a Buy and raises the price target from $5.2 to $5.7.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 550 companies achieved new lows for the year.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 193 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 539 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 588 stocks hit new 52-week lows.
-
4 years ago benzinga.com
HC Wainwright & Co. Maintains Buy on Uranium Royalty, Raises Price Target to $5.2
HC Wainwright & Co. analyst Heiko Ihle maintains Uranium Royalty (NASDAQ:UROY) with a Buy and raises the price target from $5 to $5.2.
-
4 years ago benzinga.com
10 Uranium And Nuclear Power Stocks To Watch Amid Musk, Dorsey Voicing Support And Kazakhstan Protests
Uranium and nuclear stocks are in the spotlight with several news items leading to investors searching for stocks with exposure to the sector.
-
4 years ago benzinga.com
61 Biggest Movers From Yesterday
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination…
-
4 years ago benzinga.com
35 Stocks Moving In Monday's Mid-Day Session
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a…
-
4 years ago benzinga.com
Mid-Morning Market Update: Markets Open Higher; AutoZone Tops Q1 Views
Following the market opening Tuesday, the Dow traded up 1.52% to 35,761.30 while the NASDAQ rose 2.84% to 15,656.94. The S&P also rose, gaining 2.04% to 4,685.39.